RAMP2

Protein-coding gene in the species Homo sapiens
RAMP2
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

4RWF, 2XVT, 3AQE, 3AQF

Identifiers
AliasesRAMP2, entrez:10266, receptor activity modifying protein 2
External IDsOMIM: 605154; MGI: 1859650; HomoloGene: 4274; GeneCards: RAMP2; OMA:RAMP2 - orthologs
Gene location (Human)
Chromosome 17 (human)
Chr.Chromosome 17 (human)[1]
Chromosome 17 (human)
Genomic location for RAMP2
Genomic location for RAMP2
Band17q21.2Start42,758,447 bp[1]
End42,763,041 bp[1]
Gene location (Mouse)
Chromosome 11 (mouse)
Chr.Chromosome 11 (mouse)[2]
Chromosome 11 (mouse)
Genomic location for RAMP2
Genomic location for RAMP2
Band11 D|11 64.47 cMStart101,136,854 bp[2]
End101,150,372 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • right lung

  • gastric mucosa

  • apex of heart

  • upper lobe of left lung

  • tibial nerve

  • canal of the cervix

  • subcutaneous adipose tissue

  • right coronary artery

  • left uterine tube

  • right lobe of thyroid gland
Top expressed in
  • right lung

  • right lung lobe

  • left lung

  • left lung lobe

  • external carotid artery

  • atrium

  • internal carotid artery

  • carotid body

  • endocardial cushion

  • yolk sac
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • coreceptor activity
  • protein binding
  • adrenomedullin receptor activity
  • amylin receptor activity
  • adrenomedullin binding
Cellular component
  • cytoplasm
  • integral component of membrane
  • membrane
  • plasma membrane
  • receptor complex
  • integral component of plasma membrane
  • cell surface
  • clathrin-coated pit
  • lysosome
  • amylin receptor complex 2
  • adrenomedullin receptor complex
Biological process
  • negative regulation of endothelial cell apoptotic process
  • G protein-coupled receptor signaling pathway
  • response to estradiol
  • response to hypoxia
  • regulation of G protein-coupled receptor signaling pathway
  • adherens junction assembly
  • response to progesterone
  • female pregnancy
  • receptor internalization
  • sprouting angiogenesis
  • basement membrane assembly
  • positive regulation of angiogenesis
  • vasculogenesis
  • regulation of blood pressure
  • heart development
  • cellular response to hormone stimulus
  • positive regulation of gene expression
  • positive regulation of vasculogenesis
  • angiogenesis
  • bicellular tight junction assembly
  • transport
  • protein transport
  • cellular response to vascular endothelial growth factor stimulus
  • intracellular protein transport
  • protein localization to plasma membrane
  • vascular associated smooth muscle cell development
  • calcium ion transport
  • negative regulation of vascular permeability
  • cAMP biosynthetic process
  • adenylate cyclase-activating G protein-coupled receptor signaling pathway
  • amylin receptor signaling pathway
  • adrenomedullin receptor signaling pathway
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

10266

54409

Ensembl

ENSG00000131477

ENSMUSG00000001240

UniProt

O60895

Q9WUP0

RefSeq (mRNA)

NM_005854

NM_019444

RefSeq (protein)

NP_005845

NP_062317

Location (UCSC)Chr 17: 42.76 – 42.76 MbChr 11: 101.14 – 101.15 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Receptor activity modifying protein 2, also known as RAMP2, is a protein which in humans is encoded by the RAMP2 gene.[5][6]

Function

The protein encoded by this gene is a member of the RAMP family of single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). RAMPs are type I transmembrane proteins with an extracellular N-terminus and a cytoplasmic C-terminus. RAMPs are required to transport calcitonin-receptor-like receptor (CRLR) to the plasma membrane. CRLR, a receptor with seven transmembrane domains, can function as either a calcitonin gene-related peptide (CGRP) receptor or an adrenomedullin receptor, depending on which members of the RAMP family are expressed. In the presence of this (RAMP2) protein, CRLR functions as an adrenomedullin receptor. The RAMP2 protein is involved in core glycosylation and transportation of adrenomedullin receptor to the cell surface.[5]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000131477 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000001240 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: RAMP2".
  6. ^ McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (May 1998). "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor". Nature. 393 (6683): 333–9. Bibcode:1998Natur.393..333M. doi:10.1038/30666. PMID 9620797. S2CID 4364526.

Further reading

  • Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A, Kawate H, Iinuma N, Yoshizawa T, Koyama T, Fukuchi J, Iimuro S, Moriyama N, Kawakami H, Murata T, Kangawa K, Nagai R, Shindo T (January 2008). "The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity". The Journal of Clinical Investigation. 118 (1): 29–39. doi:10.1172/JCI33022. PMC 2147670. PMID 18097473.
  • Fritz-Six KL, Dunworth WP, Li M, Caron KM (January 2008). "Adrenomedullin signaling is necessary for murine lymphatic vascular development". The Journal of Clinical Investigation. 118 (1): 40–50. doi:10.1172/JCI33302. PMC 2147672. PMID 18097475.
  • Kuwasako K, Kitamura K, Nagata S, Kato J (2008). "Functions of the extracellular histidine residues of receptor activity-modifying proteins vary within adrenomedullin receptors". Biochem. Biophys. Res. Commun. 377 (1): 109–13. doi:10.1016/j.bbrc.2008.09.105. PMID 18835256.
  • Oliver KR, Wainwright A, Edvinsson L, et al. (2002). "Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature". J. Cereb. Blood Flow Metab. 22 (5): 620–9. doi:10.1097/00004647-200205000-00014. PMID 11973435.
  • Christopoulos A, Christopoulos G, Morfis M, et al. (2003). "Novel receptor partners and function of receptor activity-modifying proteins". J. Biol. Chem. 278 (5): 3293–7. doi:10.1074/jbc.C200629200. PMID 12446722.
  • Dumont CE, Muff R, Flühmann B, et al. (2002). "Paracrine/autocrine function of adrenomedullin in peripheral nerves of rats". Brain Res. 955 (1–2): 64–71. doi:10.1016/S0006-8993(02)03365-6. PMID 12419522. S2CID 33819362.
  • Kuwasako K, Cao YN, Nagoshi Y, et al. (2004). "Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins". Mol. Pharmacol. 65 (1): 207–13. doi:10.1124/mol.65.1.207. PMID 14722252.
  • Nagoshi Y, Kuwasako K, Cao YN, et al. (2004). "Tumor necrosis factor-alpha downregulates adrenomedullin receptors in human coronary artery smooth muscle cells". Peptides. 25 (7): 1115–21. doi:10.1016/j.peptides.2004.04.010. PMID 15245870. S2CID 54255777.
  • Kuwasako K, Kitamura K, Nagoshi Y, Eto T (2003). "Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins". Biochem. Biophys. Res. Commun. 301 (2): 460–4. doi:10.1016/S0006-291X(02)03072-3. PMID 12565884.
  • Wang YF, Zhang J, Li J, et al. (2004). "[Increased atria expression of receptor activity-modifying proteins in heart failure patients]". Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 21 (4): 351–4. PMID 15300632.
  • Foord SM, Marshall FH (1999). "RAMPs: accessory proteins for seven transmembrane domain receptors". Trends Pharmacol. Sci. 20 (5): 184–7. doi:10.1016/S0165-6147(99)01347-4. PMID 10354609.
  • Prado MA, Evans-Bain B, Oliver KR, Dickerson IM (2001). "The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction". Peptides. 22 (11): 1773–81. doi:10.1016/S0196-9781(01)00517-4. PMID 11754963. S2CID 37139980.
  • Bomberger JM, Parameswaran N, Hall CS, et al. (2005). "Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking". J. Biol. Chem. 280 (10): 9297–307. doi:10.1074/jbc.M413786200. PMID 15613468.
  • Udawela M, Christopoulos G, Tilakaratne N, et al. (2006). "Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors". Mol. Pharmacol. 69 (6): 1984–9. doi:10.1124/mol.105.021915. PMID 16531504. S2CID 1957141.
  • Aiyar N, Disa J, Ao Z, et al. (2002). "Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells". Biochem. Pharmacol. 63 (11): 1949–59. doi:10.1016/S0006-2952(02)00990-5. PMID 12093471.
  • Kuwasako K, Cao YN, Chu CP, et al. (2006). "Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors". J. Biol. Chem. 281 (11): 7205–13. doi:10.1074/jbc.M511147200. PMID 16410241.
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Yue W, Dacic S, Sun Q, et al. (2007). "Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation". Clin. Cancer Res. 13 (15 Pt 1): 4336–44. doi:10.1158/1078-0432.CCR-07-0015. PMID 17671114.
  • Udawela M, Christopoulos G, Morfis M, et al. (2006). "A critical role for the short intracellular C terminus in receptor activity-modifying protein function". Mol. Pharmacol. 70 (5): 1750–60. doi:10.1124/mol.106.024257. PMID 16912219. S2CID 7249716.
  • Michou L, Garnier S, Barbet S, et al. (2008). "Lack of linkage and association of adrenomedullin and its receptor genes in French Caucasian rheumatoid arthritis trio families". Clin. Exp. Rheumatol. 26 (6): 1083–6. PMID 19210874.
  • Qi T, Christopoulos G, Bailey RJ, et al. (2008). "Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function". Mol. Pharmacol. 74 (4): 1059–71. doi:10.1124/mol.108.047142. PMID 18593822. S2CID 33491956.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

  • v
  • t
  • e
Angiopoietin
  • Kinase inhibitors: Altiratinib
  • CE-245677
  • Rebastinib
CNTF
EGF (ErbB)
EGF
(ErbB1/HER1)
ErbB2/HER2
  • Agonists: Unknown/none
ErbB3/HER3
ErbB4/HER4
FGF
FGFR1
FGFR2
  • Antibodies: Aprutumab
  • Aprutumab ixadotin
FGFR3
FGFR4
Unsorted
HGF (c-Met)
IGF
IGF-1
  • Kinase inhibitors: BMS-754807
  • Linsitinib
  • NVP-ADW742
  • NVP-AEW541
  • OSl-906
IGF-2
  • Antibodies: Dusigitumab
  • Xentuzumab (against IGF-1 and IGF-2)
Others
  • Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
  • Trofinetide
LNGF (p75NTR)
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: LEVI-04 (p75NTR-Fc)
PDGFRET (GFL)
GFRα1
GFRα2
GFRα3
GFRα4
Unsorted
  • Kinase inhibitors: Agerafenib
SCF (c-Kit)TGFβ
  • See here instead.
Trk
TrkA
  • Negative allosteric modulators: VM-902A
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: ReN-1820 (TrkAd5)
TrkB
TrkC
VEGFOthers


Stub icon

This article on a gene on human chromosome 17 is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e